🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Obecholic acid is a modified bile acid and Farnesoid X receptor (FXR) agoni...
Status
Completed
Location
Beijing Friendship Hospital
Start Date
2021-09-23
Trial ID
NCT05450887
Treatments Being Tested
The main purpose of this study is to see whether heavy drinking will interf...
Status
Completed
Location
Indiana University
Start Date
2016-04
Trial ID
NCT02654236
Treatments Being Tested
The main objectives of the study were to assess the effects of Obeticholic ...
Status
Completed
Location
UC Davis Medical Center
Start Date
2012-01
Trial ID
NCT01473524
Treatments Being Tested
Study to determine the effect of the investigational drug bezafibrate (BZF)...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2022-03-21
Trial ID
NCT05239468
This is a Phase 2, multicenter, open-label, single dose and multi-dose, dos...
Status
Terminated
Location
Clinques University Saint-Luc
Start Date
2015-07-01
Trial ID
NCT05321524
The primary hypothesis was that obeticholic acid (OCA) will cause a reducti...
Status
Completed
Location
Henry Ford
Start Date
2008-01-17
Trial ID
NCT00570765
Treatments Being Tested
Primary Biliary Cholangitis (PBC) is a serious, life-threatening, bile acid...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2014-12-26
Trial ID
NCT02308111
Treatments Being Tested
The investigators propose to develop studies of obeticholic acid (OCA) in p...
Status
Completed
Location
Hammersmith Hospital, Imperial College Healthcare NHS Trust
Start Date
2012-04
Trial ID
NCT01585025
Treatments Being Tested
In participants with inadequate response/intolerance to ursodeoxycholic aci...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-27
Trial ID
NCT04053023
Treatments Being Tested
This Phase 2, double-blind, randomized, placebo-controlled, multicenter stu...
Status
Completed
Location
St. Joseph's Hospital and Medical Center
Start Date
2015-12-04
Trial ID
NCT02633956
Treatments Being Tested